Author Bio
Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries.
Follow @keithspeights
More stimulus checks are on the way. After months of political wrangling and plenty of twists and turns, most Americans will soon receive $600 stimulus checks.
For many, this money will be critical in helping make ends meet. For others who aren t struggling financially, it will be a nice bonus they could use in lots of different ways. The most important priorities for using your stimulus money are to pay all your bills and shore up your emergency fund.
The Deal Would Create the Largest Enterprise in the Cannabis Industry By Revenue
Shares of Canadian Licensed-Producers (LPs) Aphria (TSX:APHA) (NYSE:APHA) (FRA: 10E) and Tilray (NASDAQ:TLRY) (FRA: 2HQ) traded higher following the news about the two companies merging. Benzinga caught up with Aphria CEO and chairman Irwin D. Simon, who will maintain those two positions in the new company, and Tilray CEO Brendan Kennedy, who will serve in the new corporation’s board of directors alongside one other person picked by Tilray, and seven others (including Simon) from Aphria.
Source: Shutterstock
Revive’s Clinical Safety Team Has Actively Monitored the Ongoing Interim Data of Patients and Found There Have Been No Safety Concerns and No Severe Adverse Events During the Interim Analysis Enrollment Period
Author Bio
Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries.
Follow @keithspeights
It s no small feat for a stock to double within a year. After all, the average annual gain for the
S&P 500 is only around 10%. Beating that return tenfold is an impressive achievement. But to double in two consecutive years goes beyond impressive.
There probably aren t very many stocks that will pull this feat off in 2020 and 2021. However, there are three growth stocks that doubled (and a whole lot more) this year that I think have a very good chance of doing it again in the new year.
All things considered, marijuana stocks have been good to cannabis investors in 2020. In reality, people that became shareholders earlier in the year have most likely seen gains in the market. Actually, this week has seen U.S. cannabis stocks like GrowGeneration Corp. (GRWG) continue pushing their high as the week progresses. And most leading cannabis companies in the U.S. followed a similar market trend. Granted that increased legalization in the U.S. has played a big role in the revenue growth many of the top cannabis companies have been reporting. In recent financials, you can see a spike in sales in many marijuana companies across America. Recently this has also begun to take place in Canada as the derivatives market begins to add more products to the market.U.S. Cannabis Industry Growth Potential
Author Bio
Alex began writing for the Fool in early 2020 and follows companies in the healthcare sector. Formerly a researcher in the biotech industry, he leverages his science background in his work as a writer and entrepreneur. His interests include exploring his hometown of Boston, traveling in Latin America, and value investing. Follow @alexcarchidi
On Monday, Congress approved a coronavirus relief bill that includes $600 stimulus checks for most Americans. Now, investors as long as their bills are paid and emergency funds are well-padded might be wondering where to spend it. While it might be tempting to drop the cash on a highly risky stock that has a chance of exploding, it s probably a better decision for the long-term to pick a safer and more predictable stock instead.